跳至主要内容
临床试验/JPRN-UMIN000046148
JPRN-UMIN000046148招募中未知

ow-dose ketamine infusion among adolescents with treatment-resistant depression: a randomized, double-blind placebo-control study. - Low-dose ketamine infusion among adolescents with treatment-resistant depression.

Ministry of Science and Technology0 个研究点目标入组 54 人开始时间: 2021年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13years-old 至 20years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Major medical conditions (e.g., head injury, epilepsy, severe renal diseases and cancer). (2)Other axis I psychiatric disorders such as schizophrenia, delusional disorder, organic brain syndrome, and dementia. (3)Pregnancy. (4)Substance abuse in previous 6 months such as cocaine, marijuana, opium, ketamine, PCP (phencyclidine). (5)Current use of NMDA receptor antagonist (Amantadine, Rimantadine, Lamotrigine, Memantine, Dextromethorphan) (6)Alcohol abuse / dependence within 6 months. (7)Attempt suicide in hospital. (8)Allergy to ketamine. (9)Abnormal liver function in recent 3 months. (10) Abnormal ECG (i.e.:arrhythmia). (11) Fever or infection in recent 5 days.

研究者

相似试验